跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,375 条关于
“Bayer Corporation”
全部
2,375
临床试验
392
药物
176
机构
498
资讯
1,309
去年
Bayer Seeks FDA Approval to Expand Nubeqa's Indication for Metastatic Hormone-Sensitive Prostate Cancer
2年前
Darolutamide Plus ADT Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer
4年前
Bayer Seeks Expanded Approval for Darolutamide in Japan and China for Metastatic Hormone-Sensitive Prostate Cancer
3年前
Darolutamide Approved in China for Metastatic Hormone-Sensitive Prostate Cancer
3个月前
Madras High Court Rules Chennai API Maker's Vildagliptin Exports to Egypt Infringed Novartis Patent
3年前
MHRA and NHS England Fast-Track Novel Prostate Cancer Treatment Darolutamide Combination Therapy
2年前
EMA Approves Pre-filled Syringe for Eylea 8 mg, Enhancing AMD and DME Treatment
去年
Geron Corporation Advances in Myeloid Hematologic Malignancies Treatment
去年
Bayer Seeks Approval in China for Darolutamide to Treat Metastatic Hormone-Sensitive Prostate Cancer
7个月前
Darolutamide Receives Third Approval in China for Metastatic Hormone-Sensitive Prostate Cancer
第 1 页,共 131 页
上一页
下一页